The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project
- 394 Downloads
Diabetes has been associated with increased risk of breast cancer in a number of epidemiologic studies, but its effects on survival among women diagnosed with breast cancer have been examined less frequently. Importantly, prior investigations have rarely considered the influence of factors associated with diabetes such as obesity, age at diabetes diagnosis, duration of diabetes, or diabetes treatments.
We evaluated the effect of self-reported diabetes on breast cancer incidence and mortality in the Long Island Breast Cancer Study Project, which includes 1,447 breast cancer cases and 1,453 controls. Follow-up data for all-cause (n = 395) and 5-year breast cancer-specific mortality (n = 104) through December 2005 were determined for case women from the National Death Index. Adjusted logistic regression and Cox proportional hazards models were used to estimate odds ratios (OR) and hazards ratios (HR), respectively.
Postmenopausal women with diabetes were at increased risk of developing breast cancer [OR = 1.35; 95 % confidence interval (CI) = 0.99–1.85], as were those who were not of white race regardless of menopausal status [OR = 3.89; 95 % CI = 1.66–9.11]. Among case women, diabetes was associated with a modestly increased risk of death from all causes [HR = 1.65; 95 % CI = 1.18–2.29], an association that was stronger in women who were obese at breast cancer diagnosis [HR = 2.49; 94 % CI = 1.58–3.93]. In analyses restricted to diabetics, there was no statistically significant effect of duration of diabetes or type of treatment on breast cancer incidence or mortality.
Our findings suggest that diabetes may increase incidence of breast cancer in older women and non-whites, and mortality due to all causes.
KeywordsBreast cancer Diabetes Survival
This work supported by Susan G. Komen for the Cure Grant no. #KG081373; Marilyn Gentry Fellowship Program in Nutrition and Cancer; National Cancer Institute and the National Institutes of Environmental Health and Sciences Grant nos. UO1CA/ES66572 and P30ES10126.
Conflict of interest
The authors declare they have no conflict of interest.
- 2.Wild S, Roglic G, Green A, Sicree R, King H (2011) Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, AtlantaGoogle Scholar
- 10.van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. International journal of cancer. Journal International du Cancer 120:1986–1992PubMedCrossRefGoogle Scholar
- 11.Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009) Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 27:2170–2176CrossRefGoogle Scholar
- 21.Waksberg J (1978) Sampling methods for random digit dialing. J Am Statistic Assoc 73:40–46Google Scholar
- 25.Allison P (1995) Survival analysis using SAS: a practical guide. SAS Publishing, CaryGoogle Scholar
- 36.Wilson C (2011) Diabetes: long-term use of insulin glargine might increase the risk of breast cancer. Nat Rev EndocrinolGoogle Scholar
- 53.Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS (2000) Abdominal adiposity and clustering of multiple metabolic syndrome in White. Black and Hispanic americans. Ann Epidemiol 10:263–270Google Scholar
- 55.Berman DM, Rodrigues LM, Nicklas BJ, Ryan AS, Dennis KE, Goldberg AP (2011) Early Release of Selected Estimates Based on Data From the 2010 National Health Interview Survey. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, AtlantaGoogle Scholar